Categories: News

The Assistance Fund Opens New Program for Chronic Obstructive Pulmonary Disease

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Chronic Obstructive Pulmonary Disease

ORLANDO, FL / ACCESSWIRE / May 13, 2024 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with chronic obstructive pulmonary disease (COPD). The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles.

Chronic obstructive pulmonary disease is a chronic lung disease impacting millions of Americans each year. People living with COPD experience difficulty breathing, wheezing, and a daily cough.[1] Without treatment, the disease gets worse over time and can leave people requiring supplemental oxygen.

“People living with COPD should be focused on their health and wellbeing without the added worry of financial strain,” said Danielle Vizcaino, President and CEO of The Assistance Fund. “With the support of our donors, our COPD Copay Assistance Program removes many of the financial barriers patients face in accessing the critical treatment they need.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (833) 543-2796 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages over 90 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped over 190,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

[1] Mayo Clinic, “Chronic Obstructive Pulmonary Disease,”https://www.mayoclinic.org/diseases-conditions/copd/symptoms-causes/syc-20353679, accessed April 2024.

SOURCE: The Assistance Fund

View the original press release on newswire.com.

Staff

Recent Posts

CHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

Positive recommendation based on phase III INAVO120 data showing ItovebiTM (inavolisib) in combination with palbociclib…

3 hours ago

Syncromune® Inc. Announces Publication of Abstract on SYNC-T® Therapy SV-102 Phase 1 Data for Metastatic Prostate Cancer at ASCO 2025 Annual Meeting

Study Demonstrated 87% Overall Response Rate in Metastatic Prostate Cancer Patients Treated with SYNC-T, a…

3 hours ago

Think Together Expands Executive Team with Matt Scharpnick as Chief of Innovation

Think Together creates new C-suite role to fuel market innovation and transform educational outcomes as…

12 hours ago

MindHYVE.ai™ and Islamabad Diagnostic Centre Forge Strategic Alliance to Launch AGI-Powered Diagnostic Intelligence Across Pakistan

ISLAMABAD, May 22, 2025 /PRNewswire/ -- In a groundbreaking move to elevate clinical diagnostics nationwide,…

12 hours ago

Hexaware Accelerates Delivery Solutions with a New Office in Chicago

CHICAGO, May 22, 2025 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), a leading global IT services…

18 hours ago

Bulletin from the Annual General Meeting 2025

The Annual General Meeting 2025 of RaySearch Laboratories AB (publ) was held on May 22, 2025,…

18 hours ago